4D Molecular Therapeutics

Pfizer Inc. (NYSE: PFE) announced after Friday's market close it has expanded its R&D equity investment strategy to 4 early-stage scientific innovation companies. There 4 companies include: 1) BioAtla, a company that employs expertise in protein engineering to develop monoclonal...